Healthcare / Medical Care FacilitiesToronto
$4.59
+0.21 (+4.79%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $58.3M · quality 63.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
45/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.2B
P/E
41.7x
↑EV/EBITDA
10.5x
↓ROE
-0.9%
↓Gross Margin
44.2%
↓Debt/Equity
0.70
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+35.0%
FCF CAGR
+10.3%
FCF margin
6.7%
FCF / Net income
-12.77x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.40B · net income $-7.4M · FCF $94.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.40B | $1.40B | $919.7M | $776.1M | $569.1M |
| Net Income | $-7.4M | $-7.4M | $32.6M | $82000.00 | $1.4M |
| EBITDA | $155.5M | $155.5M | $117.5M | $112.9M | $97.5M |
| EPS | -0.03 | -0.03 | 0.13 | 0.07 | — |
| Gross Margin | 44.2% | 44.2% | 39.5% | 48.0% | 53.3% |
| Operating Margin | 6.6% | 6.6% | -3.3% | 4.4% | 4.2% |
| Net Margin | -0.5% | -0.5% | 3.5% | 0.0% | 0.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.70 | 0.70 | 0.49 | 0.56 | 0.49 |
| Current Ratio | 0.83 | 0.83 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $94.0M | $94.0M | $-6.7M | $58.3M | $70.1M |
| Returns | |||||
| ROE | -0.9% | -0.9% | 3.8% | 0.0% | 0.2% |
| Valuation | |||||
| P/E | 41.73 | 41.73 | 55.08 | 53.74 | — |
| EV/EBITDA | 10.46 | 10.46 | 18.01 | 11.31 | 9.72 |
| P/B | 1.34 | 1.34 | 2.10 | 1.16 | 0.87 |
| Growth & Yield | |||||
| Revenue Growth | 52.2% | 52.2% | 18.5% | 36.4% | — |
| EPS Growth | -123.1% | -123.1% | 84.8% | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+12.0%
Start / end P/E
n/dx → n/dx
EPS bridge
0.13 → -0.03
Residual
+12.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.